Action DRREDDY DR. REDDY'S LABORATORIES LIMITED
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Dr. Reddy's Laboratories Limited

Actions

DRREDDY

INE089A01023

Marché Fermé - Bombay S.E.
Autres places de cotation
 12:00:49 23/04/2024 		Varia. 5j. Varia. 1 janv.
5 954 INR -1,01 % Graphique intraday de Dr. Reddy's Laboratories Limited -1,62 % +2,69 %
03:38 Les Laboratoires Dr. Reddy's rappellent la solution orale en poudre de dichlorhydrate de saproptérine aux Etats-Unis MT
23/04 Les Laboratoires Dr. Reddy's rappellent la poudre de chlorhydrate de saproptérine en raison de problèmes de puissance MT

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Dr. Reddy's Laboratories Recalls Sapropterin Dihydrochloride Oral Solution Powder in US
Dr. Reddy's Laboratories Recalls Sapropterin Dihydrochloride Powder Over Potency Concerns
Dr Reddy Laboratories : . Reddy’s issues voluntary nationwide recall of Sapropterin Dihyochloride Powder for Oral Solution 100 mg due to Sub-potency - Form 6-K
Technology Stocks Lead Asian Equities Traded in the US as American Depositary Receipts Higher in Tuesday Trading
Dr Reddy Laboratories : Corporate_Governance_Report- March 31_2024
Dr Reddy Laboratories : . Reddy's launches Condition Management programme ‘DailyBloom™ IBS’, India’s first-ever digital integrated care plan to manage Irritable Bowel Synome - Form 6-K
Dr. Reddy's Labortories Launches Care Plan for IBS Patients
India's Biocon developing its own version of Wegovy, clinical trial likely next year
Asian Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading
Dr. Reddy's Laboratories Limited Receives an Order from the Commissioner of CGST,, Chandigarh
Asian Equities Traded in the US as American Depositary Receipts Remain Flat in Wednesday Trading
Financial, Telecoms Stocks Lead Asian Equities Traded in the US as American Depositary Receipts Sharply Lower Tuesday
Dr Reddy Laboratories : . Reddy's Investor Presentation - Sep 2023
Dr. Reddy's Launches Migraine Management Device Nerivio in Germany
Dr Reddy Laboratories : . Reddy’s launches ug-free migraine management device Nerivio® in Europe following successful launch in India - Form 6-K
Dr. Reddy's Launches Migraine Management Wearable in Germany
Dr Reddy Laboratories : Press Release Nerivio (Global) - Dr. Reddy's launches Nerivio in Europe
Dr. Reddy's subsidiary betapharm, and Theranica launch Nerivio® in Germany to provide patients with drug-free migraine treatment
Asian Equities Traded in the US as American Depositary Receipts Start Week on Strong Note in Monday Trading
Sector Update: Health Care Stocks Rise Late Afternoon
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action DRREDDY
  4. Actualités Dr. Reddy's Laboratories Limited
  5. Autres langues